MSD Republic of Korea

The latest news from Korean pharma, including how Korea can put the infrastructure in place to develop a homegrown…

Save Share

Joong Myung Cho of Korean biotech success story CrystalGenomics introduces the company’s unique drug discovery…

Save Share

Young-Shik Cho, chairman of SD Biosensor, recounts his journey leading diagnostics companies and expanding their…

Save Share

The completion of the Human Genome Project (HGP) in April 2003 with the publication of the first human genome…

Save Share

Dr Jeong-Sun Seo, chairman of Macrogen & president of the Korea Biotechnology Industry Organization (KoreaBIO),…

Save Share

Gencurix was the first Asian company to develop a prognostic diagnostic test for breast cancer. Its CEO, Dr Sangrae…

Save Share

Yeul-Hong Kim, Director of K-MASTER details the project’s success in creating a shared database of genomic data…

Save Share

Korean biosimilar firm Celltrion’s USD 266 million acquisition of Japanese outfit Takeda assets in the…

Save Share

Under the stewardship of regenerative medicine industry veteran BG Rhee, Korean firm SCM Lifescience has engaged in…

Save Share

Genome & Company, with a market cap of USD 280 million, is the highest valued microbiome company worldwide. Dr…

Save Share

After failing to attain reimbursement for its Amyotrophic Lateral Sclerosis (ALS) treatment NEURONATA-R® in Korea,…

Save Share

Kyung Suk Kim, CEO of Corestem, the first company to receive approval for a stem cell therapy for Amyotrophic…

Save Share